Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 2/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20062479 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1IDO1ALDH1A1 | |
| SCHEMBL20062485 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1IDO1ALDH1A1 | |
| SCHEMBL20062476 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1IDO1ALDH1A1 | |
| SCHEMBL20062483 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1IDO1ALDH1A1 | |
| SCHEMBL20062478 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1IDO1ALDH1A1 | |
| SCHEMBL22930027 | 0.86 | KDM4E (0.41) | KDM4EATML3MBTL1ALDH1A1GAA | |
| SCHEMBL22929904 | 0.84 | KDM4E (0.42) | KDM4EATML3MBTL1IDO1ALDH1A1 | |
| SCHEMBL20062360 | 0.82 | ALDH1A1 (0.39) | KDM4EATML3MBTL1ALDH1A1GAA | |
| SCHEMBL20062364 | 0.82 | ALDH1A1 (0.39) | KDM4EATML3MBTL1ALDH1A1GAA | |
| SCHEMBL20062356 | 0.82 | ALDH1A1 (0.39) | KDM4EATML3MBTL1ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10608185-B2 | Organic electroluminescent materials and devices | UNIVERAL DISPLAY CORPORATION (US) | 2020-03-31 | — | — | US | disclosed |
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-04-19 | — | — | US | disclosed |
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | SLCO4C1, SLCO2A1, SLCO2B1 | KDM4E 4299/4885ATM 4318/4885L3MBTL1 2321/4885 |
| US-10608185-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLCO2A1, SLCO2B1 | KDM4E 4299/4885ATM 4318/4885L3MBTL1 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.